Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Bruno Julianne | Director | 2 | $0 | $0 | 2026-02-09 |
| Fairmount Healthcare Fund II L.P. | 10% Owner | 4 | $0 | $0 | 2026-02-09 |
| Sattarzadeh Sherwin | Chief Operating Officer | 2 | $0 | $0 | 2026-01-05 |
| Hewes L. Becker | Chief Medical Officer | 2 | $0 | $0 | 2026-01-05 |
| Schambye Hans T. | Chief Executive Officer | 22 | $41.8K | $25.0K | 2026-01-02 |
| Firmani Lori | Interim CFO | 11 | $0 | $4.9K | 2026-01-02 |
| Winslow Garrett | General Counsel | 17 | $14.6K | $9.0K | 2026-01-02 |
| Prener Anne | Director | 7 | $0 | $0 | 2025-06-18 |
| WECHSLER AMY B | Director | 3 | $0 | $0 | 2025-06-18 |
| Dallas Jayson Donald Alexander | Director | 7 | $0 | $0 | 2025-06-18 |
| Munshi Amit | Director | 8 | $0 | $0 | 2025-06-18 |
| Shapiro David | Director | 4 | $0 | $0 | 2025-06-18 |
| GOLDFISCHER CARL | Director | 13 | $0 | $0 | 2025-06-18 |
| Kronmiller Matthew | EVP Strategy and CBO | 2 | $0 | $0 | 2025-01-03 |
| Freve Jonathan | Chief Financial Officer | 8 | $41.4K | $0 | 2024-01-03 |
| OrbiMed Advisors Israel II Ltd | 10% Owner | 15 | $0 | $1.21M | 2023-08-15 |
| OrbiMed Capital GP VII LLC | 10% Owner | 6 | $0 | $742.7K | 2023-07-31 |
| Khuong Chau Quang | Director, 10% Owner | 21 | $11.00M | $0 | 2023-06-14 |
| ORBIMED ADVISORS LLC | 10% Owner | 9 | $0 | $128.3K | 2023-04-17 |
| OrbiMed Genesis GP LLC | 10% Owner | 6 | $0 | $222.0K | 2023-04-06 |
| Oestreich Stephanie | Chief Business Officer | 2 | $0 | $0 | 2023-01-04 |
| Pedersen Anders | Chief Operating Officer | 7 | $0 | $0 | 2023-01-04 |
| Lindmark Bertil | Chief Medical Officer | 5 | $42.1K | $0 | 2023-01-04 |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | 17 | $11.00M | $0 | 2020-11-02 |
| Novo Holdings A/S | 10% Owner | 11 | $5.00M | $0 | 2020-11-02 |
| Christgau Stephan | Director | 3 | $1000.0K | $0 | 2020-11-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Fairmount Healthcare Fund II L | 10% Owner | M Exercise deriv | 2026-02-09 | 2026-02-12 | 2,904 | — | $0 | 574 | SEC↗ |
| Fairmount Healthcare Fund II L | 10% Owner | M Exercise deriv | 2026-02-09 | 2026-02-12 | 5,809 | — | $0 | 1,148 | SEC↗ |
| Bruno Julianne | Director | M Exercise deriv | 2026-02-09 | 2026-02-12 | 129 | — | $0 | 0 | SEC↗ |
| Fairmount Healthcare Fund II L | 10% Owner | M Exercise | 2026-02-09 | 2026-02-12 | 2,904,000 | — | $0 | 2,904,000 | SEC↗ |
| Fairmount Healthcare Fund II L | 10% Owner | M Exercise | 2026-02-09 | 2026-02-12 | 5,809,000 | — | $0 | 5,809,000 | SEC↗ |
| Bruno Julianne | Director | M Exercise | 2026-02-09 | 2026-02-12 | 129,000 | — | $0 | 137,032 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | A Award deriv | 2026-01-05 | 2026-01-07 | 528,603 | — | $0 | 528,603 | SEC↗ |
| Sattarzadeh Sherwin | Chief Operating Officer | A Award deriv | 2026-01-05 | 2026-01-26 | 444,209 | — | $0 | 444,209 | SEC↗ |
| Hewes L. Becker | Chief Medical Officer | A Award | 2026-01-05 | 2026-01-07 | 264,629 | — | $0 | 264,629 | SEC↗ |
| Sattarzadeh Sherwin | Chief Operating Officer | A Award | 2026-01-05 | 2026-01-26 | 190,376 | — | $0 | 190,376 | SEC↗ |
| Firmani Lori | Chief Financial Officer | M Exercise deriv | 2026-01-02 | 2026-01-06 | 374 | — | $0 | 726 | SEC↗ |
| Winslow Garrett | General Counsel | M Exercise deriv | 2026-01-02 | 2026-01-06 | 680 | — | $0 | 1,320 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | M Exercise deriv | 2026-01-02 | 2026-01-06 | 1,360 | — | $0 | 2,640 | SEC↗ |
| Firmani Lori | Chief Financial Officer | S Sale | 2026-01-02 | 2026-01-06 | 135 | $21.41 | $2.9K | 931 | SEC↗ |
| Firmani Lori | Chief Financial Officer | M Exercise | 2026-01-02 | 2026-01-06 | 374 | — | $0 | 1,066 | SEC↗ |
| Winslow Garrett | General Counsel | M Exercise | 2026-01-02 | 2026-01-06 | 680 | — | $0 | 2,109 | SEC↗ |
| Winslow Garrett | General Counsel | S Sale | 2026-01-02 | 2026-01-06 | 255 | $21.38 | $5.5K | 1,854 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | S Sale | 2026-01-02 | 2026-01-06 | 700 | $21.38 | $15.0K | 4,682 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | M Exercise | 2026-01-02 | 2026-01-06 | 1,360 | — | $0 | 5,382 | SEC↗ |
| Firmani Lori | Interim CFO | M Exercise deriv | 2025-07-03 | 2025-07-08 | 374 | — | $0 | 1,100 | SEC↗ |
| Winslow Garrett | General Counsel | M Exercise deriv | 2025-07-03 | 2025-07-08 | 680 | — | $0 | 2,000 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | M Exercise deriv | 2025-07-03 | 2025-07-08 | 1,360 | — | $0 | 4,000 | SEC↗ |
| Firmani Lori | Interim CFO | S Sale | 2025-07-03 | 2025-07-08 | 147 | $3.39 | $498 | 692 | SEC↗ |
| Firmani Lori | Interim CFO | M Exercise | 2025-07-03 | 2025-07-08 | 374 | — | $0 | 839 | SEC↗ |
| Winslow Garrett | General Counsel | S Sale | 2025-07-03 | 2025-07-08 | 260 | $3.39 | $881 | 1,429 | SEC↗ |
| Winslow Garrett | General Counsel | M Exercise | 2025-07-03 | 2025-07-08 | 680 | — | $0 | 1,689 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | M Exercise | 2025-07-03 | 2025-07-08 | 1,360 | — | $0 | 4,757 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | S Sale | 2025-07-03 | 2025-07-08 | 735 | $3.38 | $2.5K | 4,022 | SEC↗ |
| GOLDFISCHER CARL | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 1,440 | — | $0 | 1,440 | SEC↗ |
| WECHSLER AMY B | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 720 | — | $0 | 720 | SEC↗ |
| Prener Anne | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 720 | — | $0 | 720 | SEC↗ |
| Shapiro David | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 720 | — | $0 | 720 | SEC↗ |
| Munshi Amit | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 720 | — | $0 | 720 | SEC↗ |
| Dallas Jayson Donald Alexander | Director | A Award deriv | 2025-06-18 | 2025-06-20 | 720 | — | $0 | 720 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | M Exercise deriv | 2025-01-03 | 2025-01-07 | 2,640 | — | $0 | 5,360 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | A Award deriv | 2025-01-03 | 2025-01-07 | 16,400 | — | $0 | 16,400 | SEC↗ |
| Kronmiller Matthew | EVP Strategy and CBO | A Award deriv | 2025-01-03 | 2025-01-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Firmani Lori | Interim CFO | A Award deriv | 2025-01-03 | 2025-01-07 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Firmani Lori | Interim CFO | M Exercise deriv | 2025-01-03 | 2025-01-07 | 726 | — | $0 | 1,474 | SEC↗ |
| Winslow Garrett | General Counsel | A Award deriv | 2025-01-03 | 2025-01-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Winslow Garrett | General Counsel | M Exercise deriv | 2025-01-03 | 2025-01-07 | 1,320 | — | $0 | 2,680 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | S Sale | 2025-01-03 | 2025-01-07 | 1,341 | $5.60 | $7.5K | 3,397 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | M Exercise | 2025-01-03 | 2025-01-07 | 2,640 | — | $0 | 4,738 | SEC↗ |
| Firmani Lori | Interim CFO | S Sale | 2025-01-03 | 2025-01-07 | 261 | $5.63 | $1.5K | 465 | SEC↗ |
| Firmani Lori | Interim CFO | M Exercise | 2025-01-03 | 2025-01-07 | 726 | — | $0 | 726 | SEC↗ |
| Winslow Garrett | General Counsel | S Sale | 2025-01-03 | 2025-01-07 | 471 | $5.60 | $2.6K | 1,009 | SEC↗ |
| Winslow Garrett | General Counsel | M Exercise | 2025-01-03 | 2025-01-07 | 1,320 | — | $0 | 1,480 | SEC↗ |
| WECHSLER AMY B | Director | A Award deriv | 2024-10-11 | 2024-10-15 | 720 | — | $0 | 720 | SEC↗ |
| WECHSLER AMY B | Director | A Award deriv | 2024-10-11 | 2024-10-15 | 480 | — | $0 | 480 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | A Award deriv | 2024-10-09 | 2024-10-11 | 44,100 | — | $0 | 44,100 | SEC↗ |
| Firmani Lori | Interim CFO | A Award deriv | 2024-10-09 | 2024-10-11 | 13,000 | — | $0 | 13,000 | SEC↗ |
| Kronmiller Matthew | EVP Strategy and CBO | A Award deriv | 2024-10-09 | 2024-10-11 | 8,600 | — | $0 | 8,600 | SEC↗ |
| Winslow Garrett | General Counsel | A Award deriv | 2024-10-09 | 2024-10-11 | 15,600 | — | $0 | 15,600 | SEC↗ |
| Dallas Jayson Donald Alexander | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Shapiro David | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GOLDFISCHER CARL | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Munshi Amit | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Prener Anne | Director | A Award deriv | 2024-06-20 | 2024-06-21 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Winslow Garrett | General Counsel | A Award deriv | 2024-01-03 | 2024-01-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Freve Jonathan | Chief Financial Officer | A Award deriv | 2024-01-03 | 2024-01-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | A Award deriv | 2024-01-03 | 2024-01-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-08-15 | 2023-08-17 | 248,819 | $0.75 | $186.6K | 631,048 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-08-15 | 2023-08-17 | 38,327 | $0.75 | $28.7K | 97,204 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-08-15 | 2023-08-17 | 535,534 | $0.75 | $401.7K | 1,510,375 | SEC↗ |
| OrbiMed Capital GP VII LLC | 10% Owner | S Sale | 2023-07-31 | 2023-08-02 | 153,078 | $3.00 | $459.2K | 2,105,909 | SEC↗ |
| OrbiMed Capital GP VII LLC | 10% Owner | S Sale | 2023-07-31 | 2023-08-02 | 29,700 | $3.00 | $89.1K | 879,867 | SEC↗ |
| OrbiMed Capital GP VII LLC | 10% Owner | S Sale | 2023-07-31 | 2023-08-02 | 26,622 | $3.00 | $79.9K | 135,531 | SEC↗ |
| OrbiMed Capital GP VII LLC | 10% Owner | S Sale | 2023-07-25 | 2023-07-27 | 4,700 | $2.92 | $13.7K | 909,567 | SEC↗ |
| OrbiMed Capital GP VII LLC | 10% Owner | S Sale | 2023-07-25 | 2023-07-27 | 7,800 | $2.92 | $22.8K | 162,153 | SEC↗ |
| OrbiMed Capital GP VII LLC | 10% Owner | S Sale | 2023-07-25 | 2023-07-27 | 26,700 | $2.92 | $78.0K | 2,258,987 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-07-13 | 2023-07-17 | 52,800 | $2.40 | $126.7K | 914,267 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-07-13 | 2023-07-17 | 132,100 | $2.40 | $317.0K | 2,285,687 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-07-13 | 2023-07-17 | 9,800 | $2.40 | $23.5K | 169,953 | SEC↗ |
| Dallas Jayson Donald Alexander | Director | A Award deriv | 2023-06-17 | 2023-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Khuong Chau Quang | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GOLDFISCHER CARL | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Munshi Amit | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Prener Anne | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Shapiro David | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2023-04-17 | 2023-04-17 | 660 | $1.97 | $1.3K | 179,753 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2023-04-17 | 2023-04-17 | 8,878 | $1.97 | $17.5K | 2,417,787 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2023-04-17 | 2023-04-17 | 3,551 | $1.97 | $7.0K | 967,067 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2023-04-14 | 2023-04-17 | 28,110 | $1.86 | $52.3K | 2,426,665 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2023-04-14 | 2023-04-17 | 11,245 | $1.86 | $20.9K | 970,618 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2023-04-14 | 2023-04-17 | 2,091 | $1.86 | $3.9K | 180,413 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2023-04-13 | 2023-04-17 | 703 | $1.82 | $1.3K | 182,504 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2023-04-13 | 2023-04-17 | 3,784 | $1.82 | $6.9K | 981,863 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2023-04-13 | 2023-04-17 | 9,459 | $1.82 | $17.2K | 2,454,775 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-04-12 | 2023-04-12 | 641 | $1.81 | $1.2K | 985,647 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-04-12 | 2023-04-12 | 119 | $1.81 | $215 | 183,207 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-04-12 | 2023-04-12 | 1,603 | $1.81 | $2.9K | 2,464,234 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-04-11 | 2023-04-12 | 3,784 | $1.82 | $6.9K | 986,288 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-04-11 | 2023-04-12 | 703 | $1.82 | $1.3K | 183,326 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-04-11 | 2023-04-12 | 9,459 | $1.82 | $17.2K | 2,465,837 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-04-10 | 2023-04-12 | 34,745 | $1.79 | $62.2K | 2,500,582 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-04-10 | 2023-04-12 | 13,899 | $1.79 | $24.9K | 1,000,187 | SEC↗ |
| OrbiMed Advisors Israel II Ltd | 10% Owner | S Sale | 2023-04-10 | 2023-04-12 | 2,584 | $1.79 | $4.6K | 185,910 | SEC↗ |
| OrbiMed Genesis GP LLC | 10% Owner | S Sale | 2023-04-06 | 2023-04-07 | 487 | $2.00 | $974 | 186,613 | SEC↗ |
| OrbiMed Genesis GP LLC | 10% Owner | S Sale | 2023-04-06 | 2023-04-07 | 2,620 | $2.00 | $5.2K | 1,003,971 | SEC↗ |
| OrbiMed Genesis GP LLC | 10% Owner | S Sale | 2023-04-06 | 2023-04-07 | 6,558 | $2.00 | $13.1K | 2,510,041 | SEC↗ |
| OrbiMed Genesis GP LLC | 10% Owner | S Sale | 2023-04-05 | 2023-04-07 | 4,687 | $2.18 | $10.2K | 187,100 | SEC↗ |
| OrbiMed Genesis GP LLC | 10% Owner | S Sale | 2023-04-05 | 2023-04-07 | 63,058 | $2.18 | $137.5K | 2,516,599 | SEC↗ |
| OrbiMed Genesis GP LLC | 10% Owner | S Sale | 2023-04-05 | 2023-04-07 | 25,220 | $2.18 | $55.0K | 1,006,591 | SEC↗ |
| Lindmark Bertil | Chief Medical Officer | A Award deriv | 2023-01-04 | 2023-01-05 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Freve Jonathan | Chief Financial Officer | A Award deriv | 2023-01-04 | 2023-01-05 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Oestreich Stephanie | Chief Business Officer | A Award deriv | 2023-01-04 | 2023-01-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Winslow Garrett | General Counsel | A Award deriv | 2023-01-04 | 2023-01-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Pedersen Anders | Chief Operating Officer | A Award deriv | 2023-01-04 | 2023-01-05 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | A Award deriv | 2023-01-04 | 2023-01-05 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Dallas Jayson Donald Alexander | Director | A Award deriv | 2022-06-14 | 2022-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GOLDFISCHER CARL | Director | A Award deriv | 2022-06-14 | 2022-06-15 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Khuong Chau Quang | Director | A Award deriv | 2022-06-14 | 2022-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Prener Anne | Director | A Award deriv | 2022-06-14 | 2022-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Shapiro David | Director | A Award deriv | 2022-06-14 | 2022-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Munshi Amit | Director | A Award deriv | 2022-06-14 | 2022-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | P Buy | 2022-03-22 | 2022-03-23 | 5,000 | $2.15 | $10.8K | 52,428 | SEC↗ |
| Lindmark Bertil | Chief Medical Officer | P Buy | 2022-03-22 | 2022-03-23 | 14,604 | $2.16 | $31.5K | 16,604 | SEC↗ |
| Oestreich Stephanie | Chief Business Officer | A Award deriv | 2022-02-15 | 2022-02-15 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Freve Jonathan | Chief Financial Officer | A Award deriv | 2022-01-04 | 2022-01-06 | 118,750 | — | $0 | 118,750 | SEC↗ |
| Pedersen Anders | Chief Operating Officer | A Award deriv | 2022-01-04 | 2022-01-06 | 118,750 | — | $0 | 118,750 | SEC↗ |
| Winslow Garrett | General Counsel | A Award deriv | 2022-01-04 | 2022-01-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Lindmark Bertil | Chief Medical Officer | A Award deriv | 2022-01-04 | 2022-01-06 | 118,750 | — | $0 | 118,750 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | A Award deriv | 2022-01-04 | 2022-01-06 | 287,500 | — | $0 | 287,500 | SEC↗ |
| Freve Jonathan | Chief Financial Officer | P Buy | 2021-12-03 | 2021-12-06 | 4,000 | $2.49 | $10.0K | 12,000 | SEC↗ |
| Winslow Garrett | General Counsel | P Buy | 2021-12-03 | 2021-12-06 | 2,000 | $2.48 | $5.0K | 4,000 | SEC↗ |
| GOLDFISCHER CARL | Director | A Award deriv | 2021-11-17 | 2021-11-19 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Khuong Chau Quang | Director | A Award deriv | 2021-11-17 | 2021-11-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | P Buy | 2021-11-09 | 2021-11-10 | 4,500 | $3.50 | $15.8K | 47,428 | SEC↗ |
| Freve Jonathan | Chief Financial Officer | P Buy | 2021-11-08 | 2021-11-09 | 3,000 | $3.40 | $10.2K | 8,000 | SEC↗ |
| Freve Jonathan | Chief Financial Officer | P Buy | 2021-08-18 | 2021-08-19 | 3,000 | $3.92 | $11.8K | 5,000 | SEC↗ |
| Lindmark Bertil | Chief Medical Officer | P Buy | 2021-06-28 | 2021-06-28 | 2,000 | $5.26 | $10.5K | 2,000 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | P Buy | 2021-06-24 | 2021-06-24 | 3,000 | $5.11 | $15.3K | 42,928 | SEC↗ |
| Winslow Garrett | General Counsel | P Buy | 2021-06-23 | 2021-06-23 | 2,000 | $4.80 | $9.6K | 2,000 | SEC↗ |
| Freve Jonathan | Chief Financial Officer | P Buy | 2021-06-23 | 2021-06-23 | 2,000 | $4.74 | $9.5K | 2,000 | SEC↗ |
| Winslow Garrett | General Counsel | A Award deriv | 2021-06-15 | 2021-06-16 | 120,000 | — | $0 | 120,000 | SEC↗ |
| GOLDFISCHER CARL | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Dallas Jayson Donald Alexander | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Khuong Chau Quang | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Prener Anne | Director | A Award deriv | 2021-05-26 | 2021-05-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Prener Anne | Director | A Award deriv | 2021-01-08 | 2021-01-08 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Prener Anne | Director | A Award deriv | 2021-01-08 | 2021-01-08 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Freve Jonathan | Chief Financial Officer | A Award deriv | 2021-01-05 | 2021-01-07 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Lindmark Bertil | Chief Medical Officer | A Award deriv | 2021-01-05 | 2021-01-07 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | A Award deriv | 2021-01-05 | 2021-01-07 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Pedersen Anders | Chief Operating Officer | A Award deriv | 2021-01-05 | 2021-01-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Dallas Jayson Donald Alexander | Director | A Award deriv | 2020-11-19 | 2020-11-23 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Dallas Jayson Donald Alexander | Director | A Award deriv | 2020-11-19 | 2020-11-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 25,562 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 133,991 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 194,666 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 181,688 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 51,911 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 66,666 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 15,833 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 63,333 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 98,930 | — | $0 | 0 | SEC↗ |
| Christgau Stephan | Director | C Conversion deriv | 2020-11-02 | 2020-11-04 | 184,433 | — | $0 | 0 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 116,800 | — | $0 | 0 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 272,533 | — | $0 | 0 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 109,013 | — | $0 | 0 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 77,866 | — | $0 | 0 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 31,147 | — | $0 | 0 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 59,350 | — | $0 | 0 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 73,773 | — | $0 | 0 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 148,395 | — | $0 | 0 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 291,999 | — | $0 | 0 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | C Conversion deriv | 2020-11-02 | 2020-11-04 | 5,359 | — | $0 | 0 | SEC↗ |
| Munshi Amit | Director | C Conversion deriv | 2020-11-02 | 2020-11-04 | 1,844 | — | $0 | 0 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 116,800 | — | $0 | 0 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 272,533 | — | $0 | 0 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 109,013 | — | $0 | 0 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 77,866 | — | $0 | 0 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 31,147 | — | $0 | 0 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 148,395 | — | $0 | 0 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 59,350 | — | $0 | 0 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 73,773 | — | $0 | 0 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion deriv | 2020-11-02 | 2020-11-04 | 291,999 | — | $0 | 0 | SEC↗ |
| Pedersen Anders | Chief Operating Officer | C Conversion deriv | 2020-11-02 | 2020-11-04 | 1,441 | — | $0 | 0 | SEC↗ |
| GOLDFISCHER CARL | Director | C Conversion deriv | 2020-11-02 | 2020-11-04 | 3,688 | — | $0 | 0 | SEC↗ |
| GOLDFISCHER CARL | Director | C Conversion deriv | 2020-11-02 | 2020-11-04 | 7,475 | — | $0 | 0 | SEC↗ |
| GOLDFISCHER CARL | Director | C Conversion deriv | 2020-11-02 | 2020-11-04 | 392,367 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy | 2020-11-02 | 2020-11-04 | 333,333 | $15.00 | $5.00M | 2,497,791 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion | 2020-11-02 | 2020-11-04 | 2,164,458 | — | $0 | 2,164,458 | SEC↗ |
| Christgau Stephan | Director | P Buy | 2020-11-02 | 2020-11-04 | 66,666 | $15.00 | $1000.0K | 546,136 | SEC↗ |
| Christgau Stephan | Director | C Conversion | 2020-11-02 | 2020-11-04 | 479,470 | — | $0 | 479,470 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion | 2020-11-02 | 2020-11-04 | 822,311 | — | $0 | 822,311 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion | 2020-11-02 | 2020-11-04 | 191,787 | — | $0 | 191,787 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | C Conversion | 2020-11-02 | 2020-11-04 | 2,055,824 | — | $0 | 2,055,824 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | P Buy | 2020-11-02 | 2020-11-04 | 523,833 | $15.00 | $7.86M | 2,579,657 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | P Buy | 2020-11-02 | 2020-11-04 | 209,500 | $15.00 | $3.14M | 1,031,811 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | C Conversion | 2020-11-02 | 2020-11-04 | 13,931 | — | $0 | 39,928 | SEC↗ |
| Munshi Amit | Director | C Conversion | 2020-11-02 | 2020-11-04 | 4,793 | — | $0 | 4,793 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion | 2020-11-02 | 2020-11-04 | 2,055,824 | — | $0 | 2,055,824 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | P Buy | 2020-11-02 | 2020-11-04 | 209,500 | $15.00 | $3.14M | 1,031,811 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | P Buy | 2020-11-02 | 2020-11-04 | 523,833 | $15.00 | $7.86M | 2,579,657 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion | 2020-11-02 | 2020-11-04 | 191,787 | — | $0 | 191,787 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | C Conversion | 2020-11-02 | 2020-11-04 | 822,311 | — | $0 | 822,311 | SEC↗ |
| Pedersen Anders | Chief Operating Officer | C Conversion | 2020-11-02 | 2020-11-04 | 3,746 | — | $0 | 3,746 | SEC↗ |
| GOLDFISCHER CARL | Director | C Conversion | 2020-11-02 | 2020-11-04 | 9,587 | — | $0 | 9,587 | SEC↗ |
| GOLDFISCHER CARL | Director | C Conversion | 2020-11-02 | 2020-11-04 | 19,432 | — | $0 | 19,432 | SEC↗ |
| GOLDFISCHER CARL | Director | C Conversion | 2020-11-02 | 2020-11-04 | 1,020,036 | — | $0 | 1,020,036 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | A Award deriv | 2020-10-07 | 2020-11-04 | 519,940 | — | $0 | 519,940 | SEC↗ |
| Pedersen Anders | Chief Operating Officer | A Award deriv | 2020-10-07 | 2020-11-04 | 77,991 | — | $0 | 77,991 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | A Award deriv | 2020-09-25 | 2020-11-04 | 59,350 | $27.11 | $1.61M | 59,350 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | A Award deriv | 2020-09-25 | 2020-11-04 | 148,395 | $27.11 | $4.02M | 148,395 | SEC↗ |
| Khuong Chau Quang | Director, 10% Owner | A Award deriv | 2020-09-25 | 2020-11-04 | 73,773 | $27.11 | $2.00M | 73,773 | SEC↗ |
| Munshi Amit | Director | A Award deriv | 2020-09-25 | 2020-11-04 | 1,844 | $27.11 | $50.0K | 1,844 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | A Award deriv | 2020-09-25 | 2020-11-04 | 59,350 | $27.11 | $1.61M | 59,350 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | A Award deriv | 2020-09-25 | 2020-11-04 | 148,395 | $27.11 | $4.02M | 148,395 | SEC↗ |
| OrbiMed Israel GP II, L.P. | Director, 10% Owner | A Award deriv | 2020-09-25 | 2020-11-04 | 73,773 | $27.11 | $2.00M | 73,773 | SEC↗ |
| GOLDFISCHER CARL | Director | A Award deriv | 2020-09-25 | 2020-11-04 | 3,688 | $27.11 | $100.0K | 3,688 | SEC↗ |
| Schambye Hans T. | Chief Executive Officer | A Award deriv | 2020-06-24 | 2020-11-04 | 207,976 | — | $0 | 207,976 | SEC↗ |
| Munshi Amit | Director | A Award deriv | 2020-06-24 | 2020-11-04 | 109,187 | — | $0 | 109,187 | SEC↗ |
| Pedersen Anders | Chief Operating Officer | A Award deriv | 2020-06-24 | 2020-11-04 | 142,983 | — | $0 | 142,983 | SEC↗ |